SHIP-1 Differentially Regulates IgE-Induced IL-10 and Antiviral Responses in Human Monocytes.

Autor: Solleti SK; Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA., Matthews BE; Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA., Wu J; Biomedical Genetics and Genomics Graduate Program, University of Rochester Medical Center, Rochester, New York, USA., Rowe RK; Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.
Jazyk: angličtina
Zdroj: European journal of immunology [Eur J Immunol] 2024 Dec 12, pp. e202451065. Date of Electronic Publication: 2024 Dec 12.
DOI: 10.1002/eji.202451065
Abstrakt: IgE-mediated stimulation of monocytes regulates multiple cellular functions including cellular maturation, cytokine release, antiviral responses, and T-cell differentiation. Expression of the high-affinity IgE receptor, FcεRI, is closely linked to serum IgE levels and atopic disease. The signaling molecules regulating FcεRI effector functions have been well studied in mast cells and basophils; however, less is known about the signaling and regulatory mechanisms in monocytes. This study sought to identify regulators of IgE-mediated cytokine release in human monocytes. SHIP-1 was identified as a negative regulator of IgE-induced IL-10 production. It was also determined that IgE-mediated stimulation and SHIP-1 inhibition decreased antiviral IP-10 production after liposomal poly(I:C) stimulation, indicating differential regulation by SHIP-1 in IgE-driven and antiviral response pathways. SHIP-1 and NF-κB were activated following IgE-mediated stimulation of monocytes, and NF-κB activation was related to both SHIP-1 and FcεRIα cellular expression levels. To our knowledge, this is the first study to identify a role for SHIP-1 in regulating IgE-mediated and antiviral responses in human monocytes. Given the importance of monocytes in inflammation and immune responses, a better understanding of the signaling and regulatory mechanisms downstream of the FcεRI receptor could lead to new therapeutic targets in allergic disease.
(© 2024 Wiley‐VCH GmbH.)
Databáze: MEDLINE
Externí odkaz: